Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 223 entries
View as:

A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00548925 Org: User:
Start: 11/30/07 End: 12/31/08 Due: 12/31/09

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types

Phase: N/A Priority: Normal
NCT ID: NCT01255657 Org: User:
Start: 11/30/10 End: 11/30/12 Due: 11/30/13

Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

Phase: N/A Priority: Normal
NCT ID: NCT01064856 Org: User:
Start: 02/28/10 End: 05/31/14 Due: 05/31/15

Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00716534 Org: User:
Start: 06/30/08 End: 04/30/12 Due: 04/30/13

Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

Phase: N/A Priority: Normal
NCT ID: NCT01754129 Org: User:
Start: 12/31/12 End: 05/31/16 Due: 05/31/17

Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01095562 Org: User:
Start: 03/31/10 End: 09/30/11 Due: 09/30/12

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01741142 Org: User:
Start: 01/31/12 End: 08/31/15 Due: 08/31/16

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT01401478 Org: User:
Start: 07/31/11 End: 01/31/13 Due: 01/31/14

Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)

Phase: N/A Priority: Normal
NCT ID: NCT01155570 Org: User:
Start: 02/28/10 End: 07/31/12 Due: 07/31/13

Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01111240 Org: User:
Start: 08/31/05 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Phase: N/A Priority: Normal
NCT ID: NCT01550965 Org: User:
Start: 05/31/12 End: 04/30/15 Due: 04/30/16

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01083849 Org: User:
Start: 03/31/08 End: 12/31/13 Due: 12/31/14

Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00517790 Org: User:
Start: 08/31/07 End: 06/30/12 Due: 06/30/13

Investigation of the Effectiveness of Sevoflurane Anaesthesia in Difficult to Intubate Egyptian Patients

Phase: N/A Priority: Normal
NCT ID: NCT01749631 Org: User:
Start: 12/31/12 End: 02/28/15 Due: 02/28/16

An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT01644396 Org: User:
Start: 05/31/12 End: 09/30/13 Due: 09/30/14

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01549834 Org: User:
Start: 03/31/12 End: 10/31/13 Due: 10/31/14

A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00401570 Org: User:
Start: 03/31/05 End: 06/30/08 Due: 06/30/09

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

Phase: N/A Priority: Normal
NCT ID: NCT01273597 Org: User:
Start: 01/31/11 End: 11/30/11 Due: 11/30/12

Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT01635764 Org: User:
Start: 04/30/12 End: 08/31/16 Due: 08/31/17

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT01502423 Org: User:
Start: 01/31/12 End: 11/30/12 Due: 11/30/13

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01736189 Org: User:
Start: 10/11/12 End: 04/16/18 Due: 04/16/19

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

Phase: N/A Priority: Normal
NCT ID: NCT01185288 Org: User:
Start: 09/30/10 End: 01/31/13 Due: 01/31/14

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01474876 Org: User:
Start: 11/30/11 End: 05/31/14 Due: 05/31/15

Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01464333 Org: User:
Start: 12/16/11 End: 03/31/18 Due: 03/31/19

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

Phase: N/A Priority: Normal
NCT ID: NCT00686374 Org: User:
Start: 05/01/08 End: 04/04/17 Due: 04/04/18